Motion Sickness
📧 Sign up to get email alerts when something new happens for Motion Sickness.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Virtual Reality Sickness Questionnaire: Psychometrics in Stroke Patients
This trial update describes a study evaluating the psychometric properties of the Virtual Reality Sickness Questionnaire in stroke patients,…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Three-Axis Wearable Adaptive Vestibular Stimulator [NA]
A Mayo Clinic-sponsored trial is evaluating a three-axis wearable adaptive vestibular stimulator for motion sickness; the study is currently…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: StableEyes With Active Neurofeedback [NA]
A Johns Hopkins University study titled StableEyes With Active Neurofeedback is currently recruiting for vestibular disorders, including ves…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Evaluation of a Device to Reduce Motion Sickness and Spatial Disorientation [NA]
A clinical trial is evaluating a device to reduce motion sickness and spatial disorientation; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Vestibulo-Ocular Reflex Function in Individuals With Chronic Motion Sensitivity Cross-Sectional Study
This completed cross-sectional study evaluated vestibulo-ocular reflex function in individuals with chronic motion sensitivity (motion sickn…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance [Phase 2]
Phase 2 clinical trial evaluating intranasal scopolamine combined with sensory augmentation to mitigate motion sickness and enhance sensorim…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance [Phase 2]
Phase 2 clinical trial evaluating intranasal scopolamine combined with sensory augmentation to mitigate motion sickness during spaceflight-r…